Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Jandl, K; Thekkekara Puthenparampil, H; Marsh, LM; Hoffmann, J; Wilhelm, J; Veith, C; Sinn, K; Klepetko, W; Olschewski, H; Olschewski, A; Brock, M; Kwapiszewska, G.
Long non-coding RNAs influence the transcriptome in pulmonary arterial hypertension: the role of PAXIP1-AS1.
J Pathol. 2019; 247(3):357-370
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Hoffmann Julia
Jandl Katharina
Kwapiszewska-Marsh Grazyna
Marsh Leigh
Olschewski Andrea
Olschewski Horst
Thekkekara Puthenparampil Helene
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
In idiopathic pulmonary arterial hypertension (IPAH), global transcriptional changes induce a smooth muscle cell phenotype characterised by excessive proliferation, migration, and apoptosis resistance. Long non-coding RNAs (lncRNAs) are key regulators of cellular function. Using a compartment-specific transcriptional profiling approach, we sought to investigate the link between transcriptional reprogramming by lncRNAs and the maladaptive smooth muscle cell phenotype in IPAH. Transcriptional profiling of small remodelled arteries from 18 IPAH patients and 17 controls revealed global perturbations in metabolic, neuronal, proliferative, and immunological processes. We demonstrated an IPAH-specific lncRNA expression profile and identified the lncRNA PAXIP1-AS1 as highly abundant. Comparative transcriptomic analysis and functional assays revealed an intrinsic role for PAXIP1-AS1 in orchestrating the hyperproliferative and migratory actions of IPAH smooth muscle cells. Further, we showed that PAXIP1-AS1 mechanistically interferes with the focal adhesion axis via regulation of expression and phosphorylation of its downstream target paxillin. Overall, we show that changes in the lncRNA transcriptome contribute to the disease-specific transcriptional landscape in IPAH. Our results suggest that lncRNAs, such as PAXIP1-AS1, can modulate smooth muscle cell function by affecting multiple IPAH-specific transcriptional programmes. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. Copyright © 2018 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Find related publications in this database (Keywords)
lncRNA
vascular diseases
paxillin
pulmonary hypertension
vascular remodelling
pulmonary artery smooth muscle cells
© Meduni Graz Impressum